Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers
Clinical trial NCT02221414 · COMPLETED
Trial details
- NCT number
- NCT02221414
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-03-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.